# The EHMT2-MBLAC2 axis suppresses ribosomal DNA transcription in response to nucleolar DNA damage

**Authors:** Chenyue Wang, Qiutian Lu, Lianbao Cao, Simeng Zeng, Zihan Gao, Yinglong Yang, Xiaowen Liu, Shanshan Gao, Chao Dong

PMC · DOI: 10.1038/s41419-026-08616-1 · Cell Death & Disease · 2026-03-18

## TL;DR

This study identifies EHMT2 and MBLAC2 as key proteins that suppress ribosomal DNA transcription when DNA damage occurs in the nucleolus, linking this process to cancer growth.

## Contribution

The study discovers EHMT2 as a novel regulator of rDNA DSB-induced transcriptional suppression and its interaction with MBLAC2.

## Key findings

- EHMT2 is essential for rDNA DSB-induced transcriptional suppression and DNA repair.
- EHMT2 interacts with MBLAC2 to repress rDNA transcription upon DNA damage.
- Deficiency in EHMT2 or MBLAC2 increases cancer cell sensitivity to ribosomal stress.

## Abstract

The induction of DNA double-strand breaks (DSBs) within actively transcribed ribosomal DNA (rDNA) arrays triggers transcriptional suppression and drives nucleolar reorganization, including the formation of nucleolar caps that facilitate the engagement of DSBs with canonical DSB signaling and repair proteins. Although these nucleolar responses are critical for rDNA stability, the components that orchestrate these responses remain unclear. In this study, we identified euchromatic histone-lysine N-methyltransferase 2 (EHMT2) as a novel regulator that is essential for rDNA DSB-induced transcriptional suppression, while functioning independently of ATM-mediated nucleolar responses. We found that EHMT2 is required for the repair of rDNA DSBs and the maintenance of rDNA stability, and its deficiency can result in cellular hypersensitivity to rDNA DSBs. Global proteomic analysis revealed that EHMT2 interacts with MBLAC2 to repress rDNA transcription upon rDNA DSBs. The depletion of EHMT2 or MBLAC2 sensitized colorectal cancer cells to ribosomal stress. Furthermore, we uncovered that EHMT2 promotes colorectal tumorigenesis, revealing a novel mechanistic link between rDNA transcriptional regulation and tumor promotion. Together, our findings established the EHMT2-MBLAC2 axis as a pivotal regulator of mammalian rDNA DSB-induced transcriptional silencing that coordinates rDNA DSB repair and the maintenance of rDNA integrity during nucleolar damage.

## Linked entities

- **Genes:** EHMT2 (euchromatic histone lysine methyltransferase 2) [NCBI Gene 10919], MBLAC2 (metallo-beta-lactamase domain containing 2) [NCBI Gene 153364]
- **Proteins:** EHMT2 (euchromatic histone lysine methyltransferase 2), MBLAC2 (metallo-beta-lactamase domain containing 2)
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** Rad51 (RAD51 recombinase) [NCBI Gene 19361] {aka Rad51a, Reca}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691] {aka C23, NCL, Nsr1}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Trp53bp1 (transformation related protein 53 binding protein 1) [NCBI Gene 27223] {aka 53BP1, Tp53bp1, m53BP1, p53BP1}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, NBN (nibrin) [NCBI Gene 4683] {aka AT-V1, AT-V2, ATV, NBS, NBS1, P95}, DYRK1B (dual specificity tyrosine phosphorylation regulated kinase 1B) [NCBI Gene 9149] {aka AOMS3, MIRK}, Mblac2 (metallo-beta-lactamase domain containing 2) [NCBI Gene 72852] {aka 2900024O10Rik}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, CALCR (calcitonin receptor) [NCBI Gene 799] {aka CRT, CT-R, CTR, CTR1}, STK3 (serine/threonine kinase 3) [NCBI Gene 6788] {aka KRS1, MST2}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, Ehmt2 (euchromatic histone lysine N-methyltransferase 2) [NCBI Gene 110147] {aka Bat8, D17Ertd710e, G9a, KMT1C, NG36}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, RPL5 (ribosomal protein L5) [NCBI Gene 6125] {aka L5, MSTP030, PPP1R135, uL18}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, EHMT2 (euchromatic histone lysine methyltransferase 2) [NCBI Gene 10919] {aka BAT8, C6orf30, G9A, GAT8, KMT1C, NG36}, TOPBP1 (DNA topoisomerase II binding protein 1) [NCBI Gene 11073] {aka Dpb11, TOP2BP1}, FBL (fibrillarin rRNA 2'-O-methyltransferase) [NCBI Gene 2091] {aka FIB, FLRN, Nop1, RNU3IP1}, Nucleolin (nucleolin multifunctional protein) [NCBI Gene 17975] {aka B530004O11Rik, C23, D0Nds28, D1Nds28, Ncl, Nucl}, Lmnb1 (lamin B1) [NCBI Gene 16906], Brca1 (breast cancer 1, early onset) [NCBI Gene 12189], BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, UBTF (upstream binding transcription factor) [NCBI Gene 7343] {aka CONDBA, NOR-90, UBF, UBF-1, UBF1, UBF2}, MDC1 (mediator of DNA damage checkpoint 1) [NCBI Gene 9656] {aka NFBD1}, Fbl (fibrillarin) [NCBI Gene 14113] {aka FIB, FLRN, RNU3IP1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Ubtf (upstream binding transcription factor, RNA polymerase I) [NCBI Gene 21429] {aka A930005G04Rik, NOR-90, Tcfubf, UBF, UBF-1, UBF1}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, TCOF1 (treacle ribosome biogenesis factor 1) [NCBI Gene 6949] {aka MFD1, TCS, TCS1, treacle}, Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, XRCC5 (X-ray repair cross complementing 5) [NCBI Gene 7520] {aka KARP-1, KARP1, KU80, KUB2, Ku86, NFIV}, MBLAC2 (metallo-beta-lactamase domain containing 2) [NCBI Gene 153364]
- **Diseases:** colorectal tumorigenesis (MESH:D063646), Cancer (MESH:D009369), COAD (MESH:D003110), colon cancer (MESH:D015179)
- **Chemicals:** PVDF (MESH:C024865), KU-55933 (MESH:C495818), streptomycin (MESH:D013307), Borate (MESH:D001881), uridine (MESH:D014529), CCK-8 (-), paraffin (MESH:D010232), polybrene (MESH:D006583), Cycloheximide (MESH:D003513), Nonidet P40 (MESH:C010615), methanol (MESH:D000432), UNC0638 (MESH:C561310), H2O2 (MESH:D006861), penicillin (MESH:D010406), Triton X-100 (MESH:D017830), DMSO (MESH:D004121), ethanol (MESH:D000431), PBS (MESH:D007854), SDS (MESH:D012967), AOM (MESH:D001397), DAPI (MESH:C007293), Coomassie Blue (MESH:C048139), propidium iodide (MESH:D011419), sodium citrate (MESH:D000077559), PFA (MESH:C003043), DSS (MESH:D016264), DAB (MESH:C000469), PEI (MESH:D011094), Oxaliplatin (MESH:D000077150), CO2 (MESH:D002245), Tween 20 (MESH:D011136), DPBS (MESH:C012939), Alexa Fluor 488 (MESH:C000711379), H2O (MESH:D014867), propionate (MESH:D011422), 4-hydroxytamoxifen (MESH:C016601), EDTA (MESH:D004492), xylene (MESH:D014992), puromycin (MESH:D011691), NaCl (MESH:D012965), 4-OHT (MESH:C032278), urea (MESH:D014508), nitrogen (MESH:D009584)
- **Species:** Lentivirus (genus) [taxon 11646], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** threonine 555, T555D, T555A, R0309S, T555
- **Cell lines:** SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546), -1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HCT 116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), CCK-8 — Homo sapiens (Human), T-cell prolymphocytic leukemia, Cancer cell line (CVCL_5443), HCT-15 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0292), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), HCT-8 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_2478), GES1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22), -2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), S2C — Canis lupus familiaris (Dog), Canine mastocytoma, Cancer cell line (CVCL_1R44), HCT 116 I-PpoI — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_HG06)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039405/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039405/full.md

---
Source: https://tomesphere.com/paper/PMC13039405